Cytosorbents Corp 8-K

What Happened

• CytoSorbents Corporation announced its financial results for the quarter and year ended December 31, 2025 via a press release dated March 25, 2026. The company furnished that press release as Exhibit 99.1 in an 8-K filed the same day under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).

Key Details

• Event: Issued press release reporting quarterly and full-year 2025 financial results.
• Date: Press release and 8-K filed March 25, 2026.
• Period covered: Quarter and year ended December 31, 2025.
• Exhibit: Press release furnished as Exhibit 99.1 (and Inline XBRL cover page 104 embedded).

Why It Matters

• The filing notifies investors that CytoSorbents has publicly reported its latest earnings and financial condition; investors should review the furnished press release for revenue, earnings, guidance, and other operational details. The company also noted the disclosure is “furnished” (not “filed”) under the Exchange Act, meaning it is not subject to Section 18 liability and is not automatically incorporated by reference into other SEC filings.